Regulation of Breast Cancer Growth by MLK-3
Regulation of Breast Cancer Growth by MLK-3
批准号:
8394602
负责人:
AJAY NMN RANA
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2014-03-31
关键词:
AddressAnimal ModelApoptosisBindingBiological AssayBreast Cancer CellBreast Cancer TreatmentCancer Cell GrowthCancer EtiologyCancer PatientCancer cell lineCell CycleCell Cycle ProgressionCell DeathCell NucleusCell ProliferationCell physiologyCellsCessation of lifeClinical TrialsCultured CellsDevelopmentDifferentiation and GrowthDiseaseDisease remissionEquilibriumFailureFamilyFamily memberFemaleG2/M TransitionGene SilencingGeneticGoalsGrowthImmunoprecipitationIncidenceIsomeraseKnowledgeLaboratoriesM cellMalignant NeoplasmsMammary NeoplasmsMediatingMedicalMilitary PersonnelMissionModelingMusN-terminalOncogenicOperative Surgical ProceduresPathogenesisPathway interactionsPeptidylprolyl IsomerasePhosphorylationPhosphotransferasesPhysiologicalPin1 proteinPost-Translational Protein ProcessingProceduresProcessProtein KinaseProtein Kinase InhibitorsProteinsRNA InterferenceRadiationRecurrenceRegulationRoleScienceServicesSignal TransductionSignal Transduction PathwayStudy modelsTestingTherapeuticTherapeutic InterventionTimeTranslatingTumor Cell LineTyrosineUnited StatesVeteransWestern BlottingWomanXenograft procedureabstractingbasecancer cellcancer therapychemotherapyclinically significantgenetic regulatory proteininhibitor/antagonistkinase inhibitormalignant breast neoplasmmalignant phenotypemembermixed lineage kinase 3mortalityneoplastic cellneuron lossnovelnovel therapeutic interventionprotein functionprotein kinase inhibitorpublic health relevancetumorigenesistumorigenicuncontrolled cell growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Abstract/Summary Rationale: Role of protein kinases in cell functions including growth, differentiation, and cell death is well established. Phosphorylation of proteins by cognate protein kinases is a dynamic process known to profoundly influence the physiological function of proteins in the cell. This process can become dysregulated in disease states including in cancer, and attempts have been made to target certain protein kinases for therapy of breast cancer (and other cancers). The focus of this laboratory is to define the physiological functions of a novel member of a protein kinase family, called Mixed Lineage Kinases (MLKs). MLK family members are unique in the sense that they can target both Ser/Thr and tyrosine residues for phosphorylation. The function of this novel family of kinases in tumorigenesis is not well known. We have made the original observation that MLK3 directly interacts with and phosphorylates a protein called Pin1. Pin1 is known to be highly expressed in breast tumors and promotes survival and proliferation of breast cancer cells. Pin1 is a member of peptidyl prolyl cis/trans isomerase family, which binds to its substrates and isomerizes specific pSer/Thr-Pro motifs and catalytically induces conformational changes. Such conformational changes can have profound effects on the role of Pin1 substrates so as to significantly impact cellular functions. However, the mechanism by which Pin1 promotes breast cancer pathogenesis is unclear. Our observation that Pin1 is directly phosphorylated by MLK3 at a very specific residue resulting in the activation of its isomerase activities (a hall mark of increased Pin1 function) may be important in its tumorigenic function. This is supported by our observation that phospho-Pin1 is exclusively localized in the nucleus of a highly aggressive breast cancer cell line and promotes G2/M transition of cell cycle. These observations suggest that phosphorylated Pin1 might have functional target(s) in the nucleus to promote cell cycle progression. Since several targets of Pin1 exist in the nucleus and may contribute to the oncogenic process, our results would contribute to this knowledge by specifically identifying targets of the phospho-Pin1 in the nucleus and their potential role in breast cancer. Hypothesis: Based on our novel finding that Pin1 is directly phosphorylated and activated by MLK3, we hypothesize that phosphorylated Pin1 targets specific substrate(s) in the nucleus which may serve to promote breast cancer pathogenesis. Objectives: To address the above hypothesis, we propose three Specific Aims: (1) To characterize the phosphorylation of Pin1 and identify the target(s)/substrate(s) of phospho-Pin1. (2) To determine the functional consequences of Pin1 phosphorylation (by MLK3) in breast cancer pathogenesis. (3) To determine whether pharmacological or genetic disruption of MLK3 inhibits the pathological functions of Pin1 in breast cancer pathogenesis. Procedures to be used: These studies will employ a broad range of technical approaches, including gene silencing by specific RNAi/ShRNA, immunoprecipitation, kinase assays, Western blotting, cell proliferation and cell death assays. Study models will include cultured cells and xenografts of breast cancer in mice. Significance of potential new findings: The results of these studies will elucidate, for the first time, detailed mechanism by which MLK3 regulates Pin1 phosphorylation and modulates its function during breast cancer pathogenesis. Further, our results will point to the possibility of utilizing MLK inhibitor(s) as a novel therapeutic intervention for breast cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rational Combination of MAP4K4 Inhibition and Immunotherapy in Pancreatic Cancer
-
批准号:10514610
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:AJAY NMN RANA
-
依托单位:
Rational Combination of MAP4K4 Inhibition and Immunotherapy in Pancreatic Cancer
-
批准号:10343661
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:AJAY NMN RANA
-
依托单位:
Rational Combination of MAP4K4 Inhibition and Immunotherapy in Pancreatic Cancer
-
批准号:10013728
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:AJAY NMN RANA
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10293579
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:AJAY NMN RANA
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10515640
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:AJAY NMN RANA
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10047242
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:AJAY NMN RANA
-
依托单位:
Targeting Mixed Lineage Kinase3-Hedgehog Axis in Pancreatic Cancer
-
批准号:9339576
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:AJAY NMN RANA
-
依托单位:
Targeting Mixed Lineage Kinase3-Hedgehog Axis in Pancreatic Cancer
-
批准号:8820462
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:AJAY NMN RANA
-
依托单位:
Role of Sprouty 2 in Hepatocellular Carcinoma
-
批准号:8974366
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:AJAY NMN RANA
-
依托单位:
Role of Sprouty 2 in Hepatocellular Carcinoma
-
批准号:9253347
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:AJAY NMN RANA
-
依托单位:
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer
-
批准号:9266382
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2013
-
负责人:AJAY NMN RANA
-
依托单位:
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer
-
批准号:8846481
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2013
-
负责人:AJAY NMN RANA
-
依托单位:
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer
-
批准号:8643781
-
项目类别:
-
资助金额:$28.99万
-
财政年份:2013
-
负责人:AJAY NMN RANA
-
依托单位:
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer
-
批准号:8517343
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2013
-
负责人:AJAY NMN RANA
-
依托单位:
Regulation of Breast Cancer Growth by MLK-3
-
批准号:7931621
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:AJAY NMN RANA
-
依托单位:
Regulation of Breast Cancer Growth by MLK-3
-
批准号:8259051
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:AJAY NMN RANA
-
依托单位:
Regulation of Breast Cancer Growth by MLK-3
-
批准号:8195598
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:AJAY NMN RANA
-
依托单位:
Role of Mixed Lineage Kinase 3/SPRK in Stress Signaling
-
批准号:7991951
-
项目类别:
-
资助金额:$8.86万
-
财政年份:2009
-
负责人:AJAY NMN RANA
-
依托单位:
MIXED LINEAGE KINASE, SPRK IN STRESS SIGNALING
-
批准号:6363283
-
项目类别:
-
资助金额:$16.63万
-
财政年份:1999
-
负责人:AJAY NMN RANA
-
依托单位:
MIXED LINEAGE KINASE, SPRK IN STRESS SIGNALING
-
批准号:6164816
-
项目类别:
-
资助金额:$7.2万
-
财政年份:1999
-
负责人:AJAY NMN RANA
-
依托单位:
海外基金